Pharmaceutical packaging solutions provider Bilcare, on Monday, said it would sell its global clinical supplies business in the U.S. and the U.K. for $61 million (about Rs.340 crore) to Ireland-based United Drug Plc.
The two parties had signed a definitive agreement for the sale, Bilcare said in a statement.
Bilcare will retain its GCS business in Asia. Going forward, United Drug and Bilcare GCS Asia would work together to use their complementary resources to meet the needs of their global customers across the U.S., Europe and Asia, it added.
Bilcare is present in three verticals — pharma packaging and research, global clinical supplies and Bilcare technologies. — PTI